A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet) vs. Diclofenac (Voltaren) in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)

Trial Profile

A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet) vs. Diclofenac (Voltaren) in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2014

At a glance

  • Drugs Tramadol/paracetamol (Primary) ; Diclofenac
  • Indications Ankylosing spondylitis; Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Johnson & Johnson
  • Most Recent Events

    • 28 Apr 2010 Actual patient number (4) added as reported by ClinicalTrials.gov.
    • 06 May 2009 Actual initiation date (Sep 2008) added as reported by ClinicalTrials.gov.
    • 06 May 2009 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top